BioSpace News Archive

Hensler Surgical Products, LLC, dba Hensler Surgical Technologies (www.henslersurgical.com), announces the issuance of U.S. patent 10,493,183 covering the collection and filtration of biological material during surgical procedures, which is particularly useful in harvesting autologous bone and marrow for use with a patient during surgery.

PatientPoint platform to enhance community oncology experience at AON practices in seven states

ProMedica National Social Determinants of Health Institute today announced the creation of the Ebeid Data Nerve Center and partnership with Socially Determined, a health care data analytics company.

Biosero, Inc. announced a new partnership wherein RORZE Lifescience, Inc., a subsidiary of Rorze, Inc. (TYO: 6323), will commercialize Biosero’s Green Button Go™ Automation Scheduling Software in Asia

Northwell Health has launched a personalized chatbot for patients with an appointment for a colonoscopy at Long Island Jewish (LIJ) Medical Center or Southside Hospital.

Immunomedics, Inc.(NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced it has commenced an underwritten public offering of $250,000,000 of shares of its common stock.

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), today announced that it was notified via email on November 27, 2019 by the U.S. Food and Drug Administration (FDA) that the Company’s Investigational New Drug (IND) application for its lead product candidate, the Cellspan Esophageal Implant (CEI), has been placed on clinical hold.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to six new employees.

Revance Therapeutics, Inc. announced a proposed underwritten public offering of its common stock.

Dr. van Es-Johansson, an expert in orphan drug development, is currently the Chief Medical Officer for AlzeCure Pharma, a Swedish pharmaceutical company with a primary focus on Alzheimer’s disease, where she is responsible for regulatory, clinical development, clinical operations, and pharmacovigilance